Results 151 to 160 of about 60,681 (284)

ANovel Approach to Reduce Toxicities and to Improve Bioavailabilities of DNA/RNAof Human Cancer Cells–Containing Cocaine (Coke), Lysergide (Lysergic AcidDiethyl Amide or LSD), Δ9–Tetrahydrocannabinol (THC) [(–)–trans–Δ⁹–Tetrahydrocannabinol],Theobromine (Xantheose),Caffeine, Aspartame (APM) (NutraSweet) and Zidovudine (ZDV)[Azidothymidine (AZT)] as Anti–Cancer Nano Drugs by Coassembly of DualAnti–Cancer Nano Drugs to Inhibit DNA/RNA of Human Cancer Cells Drug Resistance.

, 2018
Alireza Heidari, Ricardo Gobato
openalex   +2 more sources

HIPPOCAMPAL ALTERATIONS AND COGNITIVE IMPAIRMENT IN SWISS ALBINO MICE EXPOSED TO PRENATAL ZIDOVUDINE

Harsha V Nair
openalex   +2 more sources

Development and validation of methodology for HPLC-PDA for therapeutic monitoring of plasma levels of zidovudine and efavirenz

, 2009
Amanda Queiroz Soares
openalex   +1 more source

Simultaneous equation method for the estimation of Lamivudine, Nevirapine and Zidovudine in Bulk and tablet dosage forms

, 2014
Ramesh Jayaprakash, Senthilkumar Natesan, Vijay Amirtharaj Ramasamy, Rajasekhar Kommi, Kiran R Gandhi   +4 more
openalex   +1 more source

A Novel Polymorphism at Codon 333 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Can Facilitate Dual Resistance to Zidovudine and l -2′,3′-Dideoxy-3′-Thiacytidine [PDF]

, 1998
Sharon D. Kemp, Chaofu Shi, Stuart Bloor, P. Richard Harrigan, John W. Mellors, Brendan Larder   +5 more
openalex   +1 more source

Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectively. [PDF]

, 1997
Angélique B. van ’t Wout, L. Ran, Menno D. de Jong, Margreet Bakker, Remko van Leeuwen, Daan W. Notermans, A Loeliger, F. de Wolf, S. A. Danner, Peter Reiss, Charles A. Boucher, Joep M. A. Lange, Hanneke Schuitemaker   +12 more
openalex   +1 more source

Incidence and correlates of chronic anemia in people living with HIV Initiating ART: An exploratory five-year retrospective cohort of patients retained in care. [PDF]

PLOS Glob Public Health
Kamvuma K, Hamooya BM, Mulemena JA, Masenga SK, Kirabo A, Munsaka SM.   +5 more
europepmc   +1 more source

Improvement of the predictive value of CD4+ lymphocyte count by b2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate [PDF]

, 1993
Bek, Barbara, Bogner, Johannes R., Burkowitz, Jörg, Koch, Judith, Koch, Meinrad A., Schwartländer, Bernhard, Skarabis, Horst   +6 more
core  

Mitochondrial myopathy caused by long-term zidovudine therapy.

New England Journal of Medicine, 1990
M. Dalakas, I. Illa, G. Pezeshkpour, J. Laukaitis, Bruce Cohen, J. L. Griffin   +5 more
semanticscholar   +1 more source

Determination of human immunodeficiency virus RNA in plasma and cellular viral DNA genotypic zidovudine resistance and viral load during zidovudine-didanosine combination therapy [PDF]

, 1995
Mark Holodniy, L Molé, David M. Margolis, J. Moss, Haozhi Dong, Elizabeth W. Boyer, M S Urdea, Janice A. Kolberg, Scott W. Eastman   +8 more
openalex   +1 more source